LabCentral 238 has secured $12.5m from founding sponsor Astellas, which will also provide capital for LabCentral's existing incubator.
Pharmaceutical firm Astellas has committed $12.5m to become the founding sponsor of a biotech incubator that will be launched by US-based laboratory space provider and startup hub LabCentral.
The new hub, dubbed LabCentral 238, will be located in Cambridge, Massachusetts and will also be supported by a $5m grant from public-private economic development and investment agency Massachusetts Life Sciences Center.
LabCentral 238 will open in 2021 with capacity for about 20 startups and will incorporate core lab space to facilitate…
